Nov 27, 2025 · Advanced Science, part of the prestigious Wiley Advanced portfolio, is an open access interdisciplinary science journal publishing the best-in-class fundamental and applied research in …

Our journal is managed by professional in-house editors who handle manuscripts from submission to publication and beyond, including overseeing peer review and production steps and liaising with the …

Volume 12, Issue 24 Special Issue: Nanoenergy and Nanosystems for Healthcare

The journal strives to achieve a responsible and objective decision regarding publication, without bias. Where a personal conflict of interest arises, editors will refrain from handling such manuscripts.

Advanced Science is an Open Access journal: authors of accepted articles pay an article publication charge, and their articles are published under a Creative Commons license.

Tumor-informed circulating tumor DNA (ctDNA) analysis identifies patients with advanced non-small cell lung cancer (NSCLC) who benefit from first-line immunotherapy plus chemotherapy.

Copyright © 1999-2025 John Wiley & Sons, Inc or related companies. All rights reserved, including rights for text and data mining and training of artificial ...

Advanced Science, EarlyView. Three‐Year Follow‐Up of Neoadjuvant Tislelizumab with Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Revealing …

Jan 9, 2025 · As we celebrated the journal's 10th anniversary, we built on a decade of success by expanding the focus areas of Advanced Science, paving the way for even greater contributions to the …

Kirsten joined Wiley-VCH in 2007 and is the publisher for the Macromolecular family of journals and editor-in-chief of Advanced Science.